Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

BRINCIDOFOVIR ORAL SUS

Active
SPE2DP-27-T-0212Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-27-T-0212 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of two bottles of Brincidofovir 10mg/mL Oral Suspension (Tembexa), identified by NSN 6505017350149. The drug is FDA-regulated and requires strict storage between 20 C and 25 C, protection from freezing, and must be discarded 30 days after the first opening. The item carries a non-extendable shelf life of 60 months. Delivery is required within 20 days of award, with a required delivery date of November 2, 2026, shipped FOB destination to the Walter Reed National Military Medical Center in Bethesda, Maryland. The contract mandates compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires packaging and palletization in accordance with MIL-STD-2073-1E and DLA packaging requirements (RP001). Inspection and acceptance will occur at the destination. Payment must be processed electronically via the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include DFARS 252.204-7012 for safeguarding covered defense information and DFARS 252.225-7001 regarding the Buy American and Balance of Payments Program. All quotations must be submitted through the DLA Internet Bid Board System (DIBBS) by November 9, 2026.

General Info

Small business solicitation for two bottles of Brincidofovir for Walter Reed Medical Center.

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

8901 WISCONSIN AVE, BLDG 54, BETHESDA, MD, 20889-5600, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
BRINCIDOFOVIR ORAL SUSPENSION
BRINCIDOFOVIR ORAL SUSPENSION (TEMBEXA)
BRINCIDOFOVIR 10MG/ML ORAL SUSPENSION (TEMBEXA). STORE AT 20 C TO 25 C
(68 F TO 77 F); USP CONTROLLED ROOM TEMPERATURE. DISCARD UNUSED PORTION
30 DAYS AFTER FIRST OPENING. PROTECT FROM FREEZING.
UOI BT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS023: Shelf-life requirement RS001 for a TYPE I (CODE S) item with a shelf life of 60 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
EMERGENT BIODEFENSE OPERATIONS LANSING 1H0B6 P/N NDC64678-0012-01
EMERGENT BIODEFENSE OPERATIONS LANSING 1H0B6 P/N NDC79622-0012-65
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018927942 0001 BT 2.000
NSN/MATERIAL:6505017350149
SPE2DP-27-T-0212
SECTION B
PR: 7018927942 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
HT0017
DIRECTOR, WRNMMC
WALTERREEDNATIONALMILITARYMEDCENTER
8901 WISCONSIN AVE, BLDG 54
BETHESDA MD 20889-5600
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
SPE2DP-27-T-0212
SECTION B
PR: 7018927942 PRLI: 0001 CONT’D
HT0017
WALTERREEDNATIONALMILITARYMEDCENTER
WALTERREEDNATIONALMILITARYMEDCENTER
8965 BROWN DRIVE, BLDG 54,WAREHOUSE
BETHESDA MD 20889-5600
US
M/F: (TCN) HT001763015114
RDD:
PROJ: TP 3
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 13
DIC: A4A DIST: ADV: 2A FC: J7
Need Ship Date:00/00/0000 Original Required Delivery Date:11/02/2026
SPE2DP-27-T-0212 NSN/Part Number: 6505-01-735-0149 Quantity: 2 BT Purchase Request: 7018927942QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
DETERGENT, SURGICAL
Solicitation # SPE2DP-27-T-0211
Solicitation SPE2DP-27-T-0211 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of surgical detergent containing 4% chlorhexidine gluconate. The requirement consists of two 8 oz bottles under NSN 6505-01-101-3759. The item is regulated by the FDA and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. Delivery is specified as FOB Destination to the USNS Henson (T-AGS 63) in FPO AE 09573, with a required delivery date of November 3, 2026, and a lead time of 20 days after order. The contract mandates strict adherence to Medical Marking Standard No. 1 and 1C, which supersede MIL-STD-129 for medical marking, although MIL-STD-129 remains applicable for general packaging and shipping labels. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with RP001 and ASTM D3951, provided that DLA Master List technical requirements take precedence. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity standards, and hazardous material labeling per 29 CFR 1910.1200.
Pharmaceutical Preparation Manufacturing

POSTED

about 2 hours ago

DEADLINE

in 8 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0210
Solicitation SPE2DP-27-T-0210 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of sunscreen preparation, identified by NSN 6505016579247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be hypoallergenic, oil-free, PABA-free, biodegradable, and sweat and water-resistant for 80 minutes. The unit of issue is a package containing 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements specify a cool, dry place between 15 and 30 degrees Celsius. The contract specifies a delivery period of 20 days after receipt of order, with an original required delivery date of November 3, 2026. Delivery is FOB Destination to the USNS Henson. Packaging must be commercial and adhere to DLA packaging requirements, with medical marking following Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it should follow ASTM D3951. Invoicing and payment will be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and specific restrictions on covered defense telecommunications equipment. Quotations are due by November 9, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 2 hours ago

DEADLINE

in 8 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS